financetom
Business
financetom
/
Business
/
Why Smart For Life (SMFL) Stock Is Volatile During Friday's Session
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Smart For Life (SMFL) Stock Is Volatile During Friday's Session
May 31, 2024 9:27 AM

Smart for Life Inc ( SMFL ) shares are trading lower by 38% to $3.70 during Friday’s session. The company entered into agreements with holders of warrants to exercise them at a reduced price.

In a Friday SEC filing the company said on December 4, 2023, it had issued warrants to purchase 250,572 shares of common stock at $10.64 per share, with 183,370 warrants still outstanding. On May 30, the company entered into agreements with holders of these warrants to exercise them at a reduced price of $4.25 per share, generating $779,322.50.

In return, the company will issue new warrants to purchase 550,110 shares at $4.25 per share, valid for 18 months. The transaction is expected to close on June 3.

The company will also file a registration statement for the resale of shares underlying the new warrants by July 15, 2024. For 15 days after the transaction closes, the company will not issue new stock or related securities, nor file any additional registration statements. This report is not an offer or solicitation for the sale of securities.

See Also: China’s ‘Decapitated’ Chip Sector Is Thrown $50B Lifeline

Should I Sell My SMFL Stock?

When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.

Shares of Smart for Life ( SMFL ) have decreased by 95.39% in the past year. An investor who bought shares of Smart for Life ( SMFL ) at the beginning of the year would take a loss of $8.08 per share if they sold it today. The stock has risen 12.95% over the past month, meaning an investor who bought shares on Apr. 1 would see a capital loss of $0.18.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Smart for Life ( SMFL ) stock currently has an RSI of 94.68, indicating overbought conditions.

For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.

SMFL has a 52-week high of $86.33 and a 52-week low of $2.28.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved